Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects - Related Studies

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

This study has been completed.

Study NCT00126074. Last updated on March 24, 2006. Information provided by Solvay Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Atrial Fibrillation
		Atrial Flutter

2	More general conditions related to this trial
		Arrhythmias, Cardiac
		Cardiovascular Diseases
		Heart Diseases
		Pathologic Processes

3	Interventions listed in this trial
		Tedisamil sesquifumarate

4	Additional drug interventions recognized in this trial
		Tedisamil

5	More general drug interventions related to this trial
		Anti-Arrhythmia Agents
		Cardiotonic Agents
		Cardiovascular Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Solvay Pharmaceuticals